Bone Biologics Corp Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Bone Biologics Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Bone Biologics Corp Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.32M shares, a 58% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.32M -1.82M -58% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 1.02M -15.7M -93.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 534K +470K +737% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 3.13M -7.22M -69.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 3.13M -7.22M -69.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 16.7M +6.35M +61.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 63.8K -10.3M -99.4% Dec 31, 2022 10-K 2024-02-21
Q3 2022 10.4M -1.92M -15.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 10.4M -20.3M -66.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 10.4M -20.3M -66.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 10.4M -1.92M -15.7% Dec 31, 2021 10-K 2023-03-30
Q3 2021 12.3M -18.4M -60% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 30.7M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 30.7M 0 0% Mar 31, 2021 10-Q 2021-05-21
Q4 2020 12.3M -18.4M -60% Dec 31, 2020 10-K 2022-03-15
Q3 2020 30.7M 0 0% Sep 30, 2020 10-Q 2021-04-15
Q2 2020 30.7M +617K +2.05% Jun 30, 2020 10-Q 2021-04-15
Q1 2020 30.7M +2.74M +9.82% Mar 31, 2020 10-Q 2021-04-15
Q4 2019 30.7M +4.23M +16% Dec 31, 2019 10-K 2021-04-15
Q3 2019 30.7M +22.2M +264% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 30.1M +25.6M +575% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 27.9M -16M -36.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 26.4M +22.1M +511% Dec 31, 2018 10-K 2020-03-30
Q3 2018 8.44M -30.6M -78.4% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 4.45M -34.4M -88.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 43.9M +5.1M +13.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 4.33M -34.5M -88.9% Dec 31, 2017 10-K 2019-03-29
Q3 2017 39.1M +249K +0.64% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 38.8M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 38.8M +746K +1.96% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 38.8M +6.62M +20.5% Dec 31, 2016 10-K 2018-04-02
Q3 2016 38.8M +7.67M +24.6% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 38.8M +9.59M +32.8% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 38.1M +13.8M +56.9% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 32.2M +7.94M +32.7% Dec 31, 2015 10-K 2017-03-30
Q3 2015 31.2M +13.2M +73.7% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 29.2M +24.1M +473% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 24.3M +19.3M +385% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 24.3M +13.3M +122% Dec 31, 2014 10-K 2016-03-28
Q3 2014 17.9M +12.9M +259% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 5.1M +98.7K +1.97% Jun 30, 2014 8-K 2014-09-25
Q1 2014 5M 0 0% Apr 30, 2014 10-Q 2014-06-23
Q4 2013 10.9M +5.93M +119% Dec 31, 2013 10-K 2015-03-31
Q3 2013 5M 0 0% Oct 31, 2013 10-Q 2014-09-15
Q2 2013 5M 0 0% Jul 31, 2013 10-Q 2013-09-11
Q1 2013 5M 0 0% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 5M 0 0% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 5M 0 0% Oct 31, 2012 10-K 2014-02-13
Q2 2012 5M 0 0% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 5M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 5M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 5M 0 0% Oct 31, 2011 10-K 2013-01-29
Q2 2011 5M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 5M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.